Claim 50% Off TipRanks Premium and Invest with Confidence
- Unlock hedge-fund level data and powerful investing tools designed to help you make smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis so your portfolio is always positioned for maximum potential
Starpharma Holdings Limited ( (AU:SPL) ) has provided an update.
Starpharma Holdings Limited has announced its 2025 Annual General Meeting, scheduled for November 14, 2025, which will be held in a hybrid format allowing both in-person and remote participation. The Board recommends shareholders vote in favor of all resolutions, emphasizing the importance of shareholder engagement and participation in the company’s strategic decisions.
The most recent analyst rating on (AU:SPL) stock is a Hold with a A$0.50 price target. To see the full list of analyst forecasts on Starpharma Holdings Limited stock, see the AU:SPL Stock Forecast page.
More about Starpharma Holdings Limited
Starpharma Holdings Limited operates in the biotechnology industry, focusing on advanced dendrimer technology to deliver meaningful patient outcomes.
YTD Price Performance: 150.0%
Average Trading Volume: 997,788
Technical Sentiment Signal: Buy
Current Market Cap: A$115M
For a thorough assessment of SPL stock, go to TipRanks’ Stock Analysis page.